Cerebral Hyperperfusion Syndrome & Post-Interventional Emergencies

Cerebral Hyperperfusion Syndrome & Post-Interventional Emergencies

Modern management of acute ischemic stroke, severe carotid occlusive disease, and complex cerebral aneurysms relies extensively on surgical revascularization (carotid endarterectomy [$CEA$], extracranial-intracranial [$EC-IC$] bypass) and endovascular interventions (carotid artery stenting [$CAS$], intracranial angioplasty, mechanical thrombectomy). While these therapies restore critical cerebral perfusion, they introduce specific perioperative emergencies that require vigilant neurocritical surveillance.

Cerebral Hyperperfusion Syndrome: Pathophysiology and Autoregulatory Exhaustion

Under normal physiological conditions, cerebral autoregulation maintains constant cerebral blood flow ($CBF$) across mean arterial pressures ($MAP$) of $50\text{--}150\text{ mmHg}$ through dynamic myogenic, metabolic, and neurovascular alterations in arteriolar caliber.

Pathophysiological Cascade

1. Chronic Severe Hypoperfusion: In long-standing high-grade carotid stenosis ($> 90\%$) or critical intracranial stenosis, distal arteriolar resistance vessels undergo maximal chronic compensatory vasodilation to maintain baseline metabolic perfusion (exhaustion of cerebrovascular reserve).
2. Vascular Autoregulatory Paralysis: Long-term maximal dilation leads to structural and functional paralysis of smooth muscle vascular tone, impairing the normal myogenic vasoconstrictor response (the Bayliss effect).
3. Hemodynamic Breakthrough: When surgical ($CEA$, bypass) or endovascular ($CAS$, angioplasty) revascularization acutely eliminates the upstream stenosis, normal systemic arterial driving pressure is suddenly transmitted directly into this paralyzed, maximally dilated capillary bed.
4. Capillary Stress Failure and Hemorrhage: Capillary hydrostatic pressures skyrocket, causing physical stress failure of the blood-brain barrier ($BBB$), massive transudation of fluid (vasogenic edema), petechial hemorrhage, and catastrophic intracerebral hemorrhage ($ICH$), which carries a mortality rate of $30\text{--}50\%$.

---

High-Risk Predictors, Clinical Triad, and Transcranial Doppler Surveillance

High-Risk Predictors

• Severe Pre-existing Stenosis: Ipsilateral carotid stenosis $> 90\%$ or critical "string sign" on angiography.
• Compromised Collateral Pathways: Contralateral carotid artery occlusion, hypoplastic anterior/posterior communicating arteries, or absent leptomeningeal collaterals.
• Impaired Cerebrovascular Reactivity ($CVR$): Demonstrated preoperatively by absent vasodilatory response to hypercapnia or intravenous acetazolamide (Diamox challenge).
• Postoperative Systemic Hypertension: Sustained postoperative systolic blood pressure exceeding $140\text{--}160\text{ mmHg}$.
• Prolonged Perioperative Ischemia: Extended cross-clamp duration during CEA or perioperative cerebral infarction.

Clinical Presentation and Timeline

While hyperperfusion can develop within hours of revascularization, the syndrome classically presents between post-procedure days 3 and 7 (with a reported range up to 14–30 days), reflecting the delayed recovery of arteriolar tone:

1. Severe Ipsilateral Throbbing Headache: Often described as excruciating, retro-orbital or temporoparietal, and strikingly out of proportion to physical exam findings.
2. Focal Motor Seizures: Typically localized to the contralateral face or hand, with a high propensity for secondary generalization or status epilepticus.
3. New Focal Neurological Deficits: Contralateral hemiparesis, hemisensory loss, aphasia, or hemineglect, frequently mimicking acute ischemic stroke or intracranial stent occlusion.

Diagnosis and Treatment

A large rise in ipsilateral MCA velocity after revascularization can raise concern for hyperperfusion, but velocity is affected by vessel caliber, systemic flow, and technical conditions. Doubling alone does not diagnose symptomatic CHS. Evaluate severe headache, seizures, confusion, or a new deficit urgently for hemorrhage, ischemia, vessel occlusion, and hyperperfusion. CT, vascular imaging, MRI, and selected perfusion studies help distinguish these processes. Do not assume all postoperative focal symptoms have the same mechanism.

Control significant hypertension with a titratable agent and a documented procedure-specific target while avoiding cerebral and systemic hypoperfusion. Carotid and bypass protocols differ according to baseline pressure, collateral dependence, hemorrhage, and symptoms; no single SBP-below-120 target applies universally. In particular, do not import an intensive carotid target into routine care after successful acute-stroke thrombectomy: the 2026 AIS guideline warns against intensive SBP reduction below 140 in the relevant post-EVT setting.

Treat actual seizures promptly, obtain EEG when indicated, and manage clinically important edema or herniation. Routine antiseizure prophylaxis for every asymptomatic velocity rise or headache is not an established universal recommendation. Surgical evacuation depends on the hemorrhage and clinical indications, not the CHS label alone. Choose antihypertensive agents with attention to heart rate, cardiac output, intracranial physiology, and local protocol; vasodilator concerns do not create a universal prohibition overriding a competing life-threatening cardiac indication.

Neuroendovascular Access-Site Complications and Procedural Emergencies

Endovascular procedures utilizing transfemoral arterial access carry distinct systemic and puncture-site complications requiring rapid critical care management:

• Retroperitoneal Hematoma ($RPH$): Results from high femoral arterial puncture above the inguinal ligament (puncturing the external iliac artery instead of the common femoral artery over the femoral head). Because the retroperitoneum accommodates large blood volumes without external swelling, hemorrhage is occult. Patients present with unexplained hypotension, tachycardia, severe lower back/flank pain, and falling hemoglobin. In a sufficiently stable patient, CT of the abdomen and pelvis, with contrast or CTA when needed to assess active bleeding, can define the source. Unstable hemorrhage requires immediate resuscitation and source-control coordination rather than waiting for imaging. Management includes rapid crystalloid/blood resuscitation, reversal of anticoagulants, manual/balloon catheter tamponade, or endovascular stenting.
• Femoral Pseudoaneurysm: Caused by inadequate post-sheath arteriotomy closure, allowing pulsatile blood to escape into peri-arterial tissues within a fibrous pseudocapsule. Presents as a painful, pulsatile groin mass with a systolic bruit. Diagnosis is established via duplex ultrasound demonstrating swirling "yin-yang" color Doppler flow. Management includes ultrasound-guided thrombin injection or surgical repair.
• Arteriovenous ($AV$) Fistula: Caused by low puncture injuring both the femoral artery and adjacent vein, producing an abnormal connection presenting with a continuous thrill and machinery-like bruit.
• Distal Thromboembolism and Dissection: Presents with acute lower extremity ischemia (the "6 Ps": pain, pallor, pulselessness, paresthesias, poikilothermia, paralysis) demanding immediate vascular intervention.